Utah Medical Products (NASDAQ:UTMD) will release its earnings data before the market opens on Monday, January 29th.
Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $0.97 earnings per share for the quarter. Utah Medical Products had a return on equity of 18.31% and a net margin of 34.31%.
Shares of Utah Medical Products (NASDAQ UTMD) opened at $89.75 on Monday. Utah Medical Products has a twelve month low of $58.50 and a twelve month high of $90.25. The firm has a market capitalization of $333.92, a price-to-earnings ratio of 24.39 and a beta of 0.78.
Separately, BidaskClub raised Utah Medical Products from a “hold” rating to a “buy” rating in a research report on Wednesday, December 6th.
About Utah Medical Products
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.